We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

55 hedge funds and large institutions have $35.3M invested in Ampio Pharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more capital invested

Capital invested by funds: $4.24M → $35.3M (+$31.1M)

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

40% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $1.64M

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

22% more funds holding

Funds holding: 45 → 55 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
55
Holders Change
+10
Holders Change %
+22.22%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
13
Reduced
10
Closed
5
Calls
$2.31M
Puts
$1.64M
Net Calls
+$662K
Net Calls Change
+$657K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.58M
2
Group One Trading
Group One Trading
Illinois
+$387K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$386K
4
VF
Virtu Financial
New York
+$128K
5
TW
Transform Wealth
Colorado
+$102K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$266K
2
NFG
Noven Financial Group
Colorado
-$137K
3
Wolverine Trading
Wolverine Trading
Illinois
-$18.8K
4
Citadel Advisors
Citadel Advisors
Florida
-$12.2K
5
Bank of America
Bank of America
North Carolina
-$10.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$83K – – –
OC
27
Oppenheimer & Co
New York
$81K – – –
ANTB
28
AMG National Trust Bank
Colorado
$81K +$31.5K +67 New
GC
29
Guggenheim Capital
Illinois
$80K -$5.17K -11 -14%
OWP
30
Obermeyer Wealth Partners
Colorado
$79K – – –
UCFA
31
United Capital Financial Advisors
Texas
$75K +$5.17K +11 +22%
JWA
32
JFS Wealth Advisors
Pennsylvania
$74K – – –
LTFS
33
Ladenburg Thalmann Financial Services
Florida
$73K – – –
Brown Advisory
34
Brown Advisory
Maryland
$68K – – –
JWM
35
Janiczek Wealth Management
Colorado
$68K – – –
PCAP
36
Pratt Collard Advisory Partners
New York
$63K +$24.4K +52 New
CC
37
Courier Capital
New York
$58K – – –
PNC Financial Services Group
38
PNC Financial Services Group
Pennsylvania
$56K – – –
MML Investors Services
39
MML Investors Services
Massachusetts
$53K – – –
GWM
40
Geneos Wealth Management
Colorado
$48K +$3.29K +7 +21%
Citadel Advisors
41
Citadel Advisors
Florida
$42K -$12.2K -26 -43%
WA
42
WealthTrust Axiom
Pennsylvania
$40K – – –
PAG
43
Private Advisor Group
New Jersey
$36K -$940 -2 -5%
Bank of America
44
Bank of America
North Carolina
$34K -$10.3K -22 -44%
Morgan Stanley
45
Morgan Stanley
New York
$30K +$3.76K +8 +50%
AWM
46
Avior Wealth Management
Nebraska
$18K +$7.05K +15 New
UBS Group
47
UBS Group
Switzerland
$15K -$3.29K -7 -37%
CCM
48
Covington Capital Management
California
$13K – – –
GSC
49
G&S Capital
Colorado
$9K +$3.29K +7 New
CTB
50
Country Trust Bank
Illinois
$8K +$3.29K +7 New
1
2
3

AMPE Hedge Fund Activity: Q4 2017 in Review

55 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2017, worth a combined $35.3M — up 733% from $4.24M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AMPE positions and 5 closed out — a net gain of 10 holders — while 13 added to existing stakes and 10 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.58M. The largest seller was Millennium Management, cutting an estimated $266K.

  • 55 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2017, up from 45 in Q3 2017.
  • Funds reported $35.3M of Ampio Pharmaceuticals Inc. stock for Q4 2017, up 733% quarter-over-quarter.
  • 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2017 and 5 closed out, a net change of +10 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2017 was Vanguard Group, an estimated $1.58M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2017 was Millennium Management, an estimated $266K sold.

Based on aggregated 13F filings for Q4 2017.